As of Jan 20
| +0.08 / +0.60%|
The 8 analysts offering 12-month price forecasts for Astellas Pharma Inc have a median target of 17.80, with a high estimate of 20.94 and a low estimate of 14.00. The median estimate represents a +32.29% increase from the last price of 13.46.
The current consensus among 8 polled investment analysts is to Buy stock in Astellas Pharma Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.